Pharmala Biotech Holdings Inc C.MDMA

Alternate Symbol(s): MDXXF

PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.

CSE:MDMA - Post by User

Pharmala Biotech Holdings Inc > MDMA.CN: Engage them rockets!

<< Previous

Bullboard Posts

Next >>

Comment by polygraph46on Jun 22, 2023 11:17am

140 Views

Post# 35509205

RE:MDMA.CN: Engage them rockets!

Evan:
There is an aweful lot of hype sourrounding MDMA. It will be interesting in July to watch how it all unfolds down under in Aussieland.
From what I have read, it does have real good potential for treatment, re mental health etc. Here's hoping, good luck to you and other holders on here....pg

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing